Safety and Tolerability of Adjunctive Lumateperone for the Treatment of Major Depressive Disorder: A Pooled Analysis of Two Randomized Placebo-Controlled Trials.

Saved in:
Bibliographic Details
Title: Safety and Tolerability of Adjunctive Lumateperone for the Treatment of Major Depressive Disorder: A Pooled Analysis of Two Randomized Placebo-Controlled Trials.
Authors: Earley WR; Intra-Cellular Therapies, a Johnson & Johnson Company, 135 US Highway 202/206, Suite 6, Bedminster, NJ, 07921, USA. wearley@its.jnj.com., Durgam S; Intra-Cellular Therapies, a Johnson & Johnson Company, 135 US Highway 202/206, Suite 6, Bedminster, NJ, 07921, USA., Kozauer SG; Former Employee, Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ, USA., Chen C; Intra-Cellular Therapies, a Johnson & Johnson Company, 135 US Highway 202/206, Suite 6, Bedminster, NJ, 07921, USA., Migliore R; Intra-Cellular Therapies, a Johnson & Johnson Company, 135 US Highway 202/206, Suite 6, Bedminster, NJ, 07921, USA., Correll CU; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.; Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany.; German Center for Mental Health (DZPG), partner site Berlin, Berlin, Germany.
Source: CNS drugs [CNS Drugs] 2026 Jul 15. Date of Electronic Publication: 2026 Jul 15.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42455478
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Tolerability of Adjunctive Lumateperone for the Treatment of Major Depressive Disorder: A Pooled Analysis of Two Randomized Placebo-Controlled Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Earley+WR%22">Earley WR</searchLink>; Intra-Cellular Therapies, a Johnson & Johnson Company, 135 US Highway 202/206, Suite 6, Bedminster, NJ, 07921, USA. wearley@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Durgam+S%22">Durgam S</searchLink>; Intra-Cellular Therapies, a Johnson & Johnson Company, 135 US Highway 202/206, Suite 6, Bedminster, NJ, 07921, USA.<br /><searchLink fieldCode="AU" term="%22Kozauer+SG%22">Kozauer SG</searchLink>; Former Employee, Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; Intra-Cellular Therapies, a Johnson & Johnson Company, 135 US Highway 202/206, Suite 6, Bedminster, NJ, 07921, USA.<br /><searchLink fieldCode="AU" term="%22Migliore+R%22">Migliore R</searchLink>; Intra-Cellular Therapies, a Johnson & Johnson Company, 135 US Highway 202/206, Suite 6, Bedminster, NJ, 07921, USA.<br /><searchLink fieldCode="AU" term="%22Correll+CU%22">Correll CU</searchLink>; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.; Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany.; German Center for Mental Health (DZPG), partner site Berlin, Berlin, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2026 Jul 15. <i>Date of Electronic Publication: </i>2026 Jul 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42455478
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40263-026-01314-8
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Safety and Tolerability of Adjunctive Lumateperone for the Treatment of Major Depressive Disorder: A Pooled Analysis of Two Randomized Placebo-Controlled Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Earley WR
      – PersonEntity:
          Name:
            NameFull: Durgam S
      – PersonEntity:
          Name:
            NameFull: Kozauer SG
      – PersonEntity:
          Name:
            NameFull: Chen C
      – PersonEntity:
          Name:
            NameFull: Migliore R
      – PersonEntity:
          Name:
            NameFull: Correll CU
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: 2026 Jul 15
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1934
          Titles:
            – TitleFull: CNS drugs
              Type: main
ResultId 1